Lingbo Biology
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- $15M
Investors
- 6
About Lingbo Biology
Based in Hangzhou, China, and established in 2019, Lingbo Biology is a medical equipment manufacturing company that focuses on the development and production of bio-based artificial blood vessel medical devices. Deling Kong, the founder of the company, is a professor in the College of Life Sciences of Nankai University and the director of the International Society of Blood Purification. In 2019, the company participated in the China Medical Device Innovation and Entrepreneurship Competition. The company's main business is the research and development of regenerative repair materials and regenerative artificial organs. Products can be categorized into artificial blood vessels, artificial esophagus, and vascular patches. The specification of its artificial blood vessel products surpassed 6mm caliber. At present, the company has built 3 major technology platforms, which are decellularized matrix, 3D printing, and hydrogel. It also developed technology for polymer decellularization bonding. The products mainly serve patients with heart bypass, hemodialysis, peripheral vascular, and other diseases. The company generates revenue by providing regenerative repair materials and regenerative artificial organs.
Who invested in Lingbo Biology
6 investors across 3 rounds
See all investors in Lingbo Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lingbo Biology
Who invested in Lingbo Biology?
Lingbo Biology has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lingbo Biology raised?
Lingbo Biology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Lingbo Biology last raise money?
Lingbo Biology's most recent round on record is a Series A, in Jun 2024.
What does Lingbo Biology do?
Based in Hangzhou, China, and established in 2019, Lingbo Biology is a medical equipment manufacturing company that focuses on the development and production of bio-based artificial blood vessel medical devices.
Where is Lingbo Biology headquartered?
Lingbo Biology is headquartered in Hangzhou, China.
Which VCs invest in companies like Lingbo Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Lingbo Biology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Lingbo Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.